Compare ImmunityBio Inc. Common Stock (IBRX) vs Ovintiv Inc. (DE) (OVV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Ovintiv Inc. (DE) — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while Ovintiv Inc. (DE) trades at $62.88 (market cap $16.99B). The key difference: Ovintiv Inc. (DE) is the larger of the two by market cap, and Ovintiv Inc. (DE) pays a 1.95% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Ovintiv Inc. (DE) for 0 Days on average.
| IBRX | OVV | |
|---|---|---|
Market Cap | $10.33B | $16.99B |
Volume | 11,745,198 | 3,019,678 |
Sector | Health | Energy |
52-Week High | $11.55 | $66.97 |
52-Week Low | $1.98 | $35.97 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $21.32B |
Dividend Yield | — | 1.95% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Ovintiv Inc. (DE)
Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.
Read more on OVV →
